Navigation Links
La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial

LJPC. More information about the Company is available on its Web site: http://www.ljpc.com.

The forward-looking statements in this press release involve significant risks and uncertainties, and a number of factors, both foreseen and unforeseen, could cause actual results to differ materially from our current expectations. Forward-looking statements include those that express a plan, belief, expectation, estimation, anticipation, intent, contingency, future development or similar expression. The analyses of clinical results of Riquent, previously known as LJP 394, our drug candidate for the treatment of systemic lupus erythematosus ("lupus"), and any other drug candidate that we may develop, including the results of any trials or models that are ongoing or that we may initiate in the future, could result in a finding that these drug candidates are not effective in large patient populations, do not provide a meaningful clinical benefit, or may reveal a potential safety issue requiring us to develop new candidates. The analysis of the data from our previous Phase 3 trial of Riquent showed that the trial did not reach statistical significance with respect to its primary endpoint, time to renal flare, or with respect to its secondary endpoint, time to treatment with high-dose corticosteroids or cyclophosphamide. The results from our clinical trials of Riquent, including the results of any trials that are ongoing or that we may initiate in the future, may not ultimately be sufficient to obtain regulatory clearance to market Riquent either in the United States or any other country, and we may be required to conduct additional clinical studies to demonstrate the safety and efficacy of Riquent in order to obtain marketing approval. There can be no assurance, however, that we will have the necessary resources to complete any current or future trials or that any such trials will sufficiently demonstrate the safety and
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:7/27/2015)... WASHINGTON , July 27, 2015 Even ... Larkin , MD, FACP, NCMP, as scientific co-chair for ... health coalition to serve as an expert voice in ... treatment options for women struggling with Hypoactive Sexual Desire ... "I am honored to join Even ...
(Date:7/27/2015)... , July 20, 2015 Research and Markets ... "Medical Device Regulation in Asia/Pacific Markets Seminar" ... the European Medical Device market is well established, the ... China , together with other countries ... the process of implementing, their own medical device regulations. ...
(Date:7/27/2015)... , July 27, 2015 ... announced the addition of the "Wound ... And Opportunities: 2015-2020 Analysis And Forecasts" ... Comprehensive information and evaluation of the global ... of manufacturers, segmentation, product offerings, competitive shares, ...
Breaking Medicine Technology:Dr. Lisa Larkin Joins the Even the Score Coalition as Scientific Co-Chair 2Dr. Lisa Larkin Joins the Even the Score Coalition as Scientific Co-Chair 3Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2Global Wound Care Markets 2015-2020 - Traditonal, Advanced And Regenerative: Competitors And Opportunities 2
... of Nucleoside-Naive Chronic Hepatitis B e-Antigen,(HBeAg)-Negative Patients ... Re-Treatment, PRINCETON, N.J., April 13, 2007 /PRNewswire-FirstCall/ ... a cohort of,nucleoside-naive HBeAg-negative chronic hepatitis B ... who,experienced recurrent levels of hepatitis B virus ...
... HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Apr 12, 2007 - ... for Cancer Research (AACR) at the Los ... Company will feature,Immunicon Pharma Services(SM), the new ... System at booth 1604., Immunicon Pharma Services ...
Cached Medicine Technology:Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 2Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 3Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 4Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 5Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR 2Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR 3Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR 4
(Date:7/27/2015)... ... July 27, 2015 , ... North Central Surgical Center ... , The center invites all those prospective joint-replacement patients, along with their friends and ... each month, with Monday classes (Aug 6, Sept 8 [Tue due to Labor Day], ...
(Date:7/27/2015)... ... July 27, 2015 , ... David Gilmour ... will be performing for one additional night at each of his original four tour ... for added savings. , David Gilmour’s 2016 North America tour dates: , Thursday, March ...
(Date:7/27/2015)... ... July 27, 2015 , ... In an ongoing program ... to its options. Already an industry leader because of its use of iPad ... the latest successful trends in helping people to overcome addiction and live healthy, ...
(Date:7/27/2015)... ... July 27, 2015 , ... Throughout its 20 year history, ... medical providers working on a lien basis. As the personal injury and medical ... providers from chiropractors, to orthopedists, to pain management physicians, to psychologists and more. ...
(Date:7/27/2015)... ... 27, 2015 , ... For a limited time, Huntington Beach dentist , ... is a great time to change up a look or to simply brighten a ... affect your self-esteem. Over time, the enamel coating can become worn and can expose ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2Health News:Cheap David Gilmour Tickets at Madison Square Garden (MSG), Air Canada Center, United Center and Hollywood Bowl: Additional Dates for David Gilmour Go On Sale Today 2Health News:Hiking Adds Benefits to Recovery at Serenity Palms 2Health News:Hiking Adds Benefits to Recovery at Serenity Palms 3Health News:Doctors on Liens Adds Highly Respected Physical Therapy Office in Los Angeles 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 3
... has increased in infants born prematurely in the US, ... Health System (LUHS). These findings were reported at the ... in Chicago. They also were published in the latest ... Gynecology . , Researchers reported that CP is associated ...
... ... treat anxiety disorders. A new self-help book written by a former extreme anxiety ... ... 40 million Americans suffer from anxiety disorders, a figure that doesn,t include the bulk ...
... warn of Torsade de Pointes in new scientific statement ... other health-care professionals need to be aware that certain ... problem called Torsade de Pointes (TdP), says a joint ... American College of Cardiology. , The rhythm disturbance is ...
... Feb. 9 Alan Revell of Milford worked ... What he witnessed was the inspiration for the newly formed Caring Rose Home ... be a better way to treat our elderly loved ones," said Revell, President/CEO ... enough to change my life. There are many respectable nursing homes, but I ...
... , Military brass support improved school nutrition to cut obesity, ... General Johnnie E. Wilson , U.S. Army (Ret.), ... said Tuesday that preventing child obesity is a matter of national ... why potential recruits are unable to enlist in the armed services. ...
... MOUNTAIN VIEW, Calif. , Feb. 9 Sheila ... has been re-elected Western Chapters Coordinator-Elect (CCE) of the American Nephrology ... Research of Satellite Healthcare will assume her position during ANNA,s 41st ... 2010 . , As Western CCE, Doss will coordinate and supervise regional ...
Cached Medicine News:Health News:Incidence of cerebal palsy on rise in United States 2Health News:Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy 2Health News:ICU Patients at Risk for Rare Heart Rhythm Problem 2Health News:Caring Rose Home Care Launched To Help Seniors Live Independently 2Health News:Retired Military Brass Support First Lady's Call to Reduce Child Obesity, Improve Nutrition 2Health News:Satellite Healthcare's Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses' Association 2Health News:Satellite Healthcare's Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses' Association 3
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Medicine Products: